{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:39:50Z","timestamp":1792496390006,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T00:00:00Z","timestamp":1278374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/nrneph.2010.85","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T07:56:26Z","timestamp":1278402986000},"page":"494-499","source":"Crossref","is-referenced-by-count":329,"title":["C3 glomerulopathy: a new classification"],"prefix":"10.1038","volume":"6","author":[{"given":"Fadi","family":"Fakhouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure-H\u00e9l\u00e8ne","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"BFnrneph201085_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jmg.2006.045328","volume":"44","author":"A Servais","year":"2007","unstructured":"Servais, A.  et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J. Med. Genet. 44, 193\u2013199 (2007).","journal-title":"J. Med. Genet."},{"key":"BFnrneph201085_CR2","unstructured":"Alchi, B. & Jayne, D. Membranoproliferative glomerulonephritis. Pediatr. Nephrol. doi:10.1007\/s00467-009-1322\u20131327."},{"key":"BFnrneph201085_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ki.1975.32","volume":"7","author":"R Habib","year":"1975","unstructured":"Habib, R., Gubler, M. C., Loirat, C., Maiz, H. B. & Levy, M. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int. 7, 204\u2013215 (1975).","journal-title":"Kidney Int."},{"key":"BFnrneph201085_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/modpathol.3800773","volume":"20","author":"PD Walker","year":"2007","unstructured":"Walker, P. D., Ferrario, F., Joh, K. & Bonsib, S. M. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod. Pathol. 20, 605\u2013616 (2007).","journal-title":"Mod. Pathol."},{"key":"BFnrneph201085_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0090-1229(78)90160-5","volume":"10","author":"M Levy","year":"1978","unstructured":"Levy, M., Gubler, M. C., Sich, M., Beziau, A. & Habib, R. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (type I MPGN). Clin. Immunol. Immunopa thol. 10, 477\u2013492 (1978).","journal-title":"Clin. Immunol. Immunopa thol."},{"key":"BFnrneph201085_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","volume":"104","author":"PJ Lachmann","year":"2009","unstructured":"Lachmann, P. J. The amplification loop of the complement pathways. Adv. Immunol. 104, 115\u2013149 (2009).","journal-title":"Adv. Immunol."},{"key":"BFnrneph201085_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1160\/TH08-09-0575","volume":"101","author":"C Licht","year":"2009","unstructured":"Licht, C. & Fr\u00e9meaux-Bacchi, V. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis. Thromb. Haemost. 101, 271\u2013278 (2009).","journal-title":"Thromb. Haemost."},{"key":"BFnrneph201085_CR8","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1073\/pnas.0812584106","volume":"106","author":"T Montes","year":"2009","unstructured":"Montes, T., Tortajada, A., Morgan, B. P., Rodriguez de Cordoba, S. & Harris, C. L. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc. Natl Acad. Sci. USA 106, 4366\u20134371 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201085_CR9","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/hmg\/ddp289","volume":"18","author":"A Tortajada","year":"2009","unstructured":"Tortajada, A.  et al. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum. Mol. Genet. 18, 3452\u20133461 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201085_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","volume":"151","author":"MC Pickering","year":"2008","unstructured":"Pickering, M. C. & Cook, H. T. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin. Exp. Immuno l. 151, 210\u2013230 (2008).","journal-title":"Clin. Exp. Immuno l."},{"key":"BFnrneph201085_CR11","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1016\/j.molimm.2007.06.003","volume":"44","author":"TS Jokiranta","year":"2007","unstructured":"Jokiranta, T. S.  et al. Where next with atypical hemolytic uremic syndrome? Mol. Immunol. 44, 3889\u20133900 (2007).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201085_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","volume":"59","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh, D., Richards, A. & Atkinson, J. Complement regulatory genes and hemolytic uremic syndromes. Annu. Rev. Med. 59, 293\u2013309 (2008).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph201085_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","volume":"23","author":"C Loirat","year":"2008","unstructured":"Loirat, C., Noris, M. & Fr\u00e9meaux-Bacchi, V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr. Nephrol. 23, 1957\u20131972 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201085_CR14","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1681\/ASN.2007030356","volume":"18","author":"RJ Smith","year":"2007","unstructured":"Smith, R. J.  et al. New approaches to the treatment of dense deposit disease. J. Am. Soc. Nephrol. 18, 2447\u20132456 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201085_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1053\/ajkd.2001.24511","volume":"37","author":"CD West","year":"2001","unstructured":"West, C. D., Witte, D. P. & McAdams, A. J. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2. Am. J. Kidney Dis. 37, 1120\u20131130 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201085_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.2008.657","volume":"75","author":"S Sethi","year":"2009","unstructured":"Sethi, S.  et al. Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int. 75, 952\u2013960 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201085_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1172\/JCI106524","volume":"50","author":"EH Vallota","year":"1971","unstructured":"Vallota, E. H., Forristal, J., Spitzer, R. E., Davis, N. C. & West, C. D. Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. J. Clin. Invest. 50, 552\u2013558 (1971).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201085_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2215\/CJN.03480708","volume":"4","author":"SH Nasr","year":"2009","unstructured":"Nasr, S. H.  et al. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin. J. Am. Soc. Nephrol. 4, 22\u201332 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201085_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1681\/ASN.2005010078","volume":"16","author":"GB Appel","year":"2005","unstructured":"Appel, G. B.  et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J. Am. Soc. Nephrol. 16, 1392\u20131403 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201085_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0272-6386(89)80004-6","volume":"13","author":"WM Bennett","year":"1989","unstructured":"Bennett, W. M.  et al. Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease. Am. J. Kidney Dis. 13, 469\u2013476 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201085_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0002-9343(83)90606-X","volume":"74","author":"JS Cameron","year":"1983","unstructured":"Cameron, J. S.  et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am. J. Med. 74, 175\u2013192 (1983).","journal-title":"Am. J. Med."},{"key":"BFnrneph201085_CR22","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1097\/01.ASN.0000022006.49966.F8","volume":"13","author":"JJ Neary","year":"2002","unstructured":"Neary, J. J.  et al. Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1. J. Am. Soc. Nephrol. 13, 2052\u20132057 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201085_CR23","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1053\/ajkd.2002.33932","volume":"40","author":"J Neary","year":"2002","unstructured":"Neary, J., Dorman, A., Campbell, E., Keogan, M. & Conlon, P. Familial membranoproliferative glomerulonephritis type III. Am. J. Kidney Dis. 40, E1 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201085_CR24","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.molimm.2009.05.198","volume":"46","author":"E Goicoechea de Jorge","year":"2009","unstructured":"Goicoechea de Jorge, E.  et al. A mutant complement factor H-related 5 protein is associated with familial C3 glomerulonephritis Mol. Immunol. 46, 2822 (2009).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201085_CR25","first-page":"2864","volume":"46","author":"l Roumenina","year":"2009","unstructured":"Roumenina, l.  et al. Acquired and hereditary complement dysregulation in patients with C3 glomerulopathy. Mol. Immunol. 46, 2864 (2009).","journal-title":"Mol. Immunol."},{"key":"BFnrneph201085_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1172\/JCI200421075","volume":"114","author":"LA Trouw","year":"2004","unstructured":"Trouw, L. A.  et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 114, 679\u2013688 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201085_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","volume":"76","author":"MC Pickering","year":"2000","unstructured":"Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J. & Walport, M. J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76, 227\u2013324 (2000).","journal-title":"Adv. Immunol."},{"key":"BFnrneph201085_CR28","first-page":"608","volume":"118","author":"KL Rose","year":"2008","unstructured":"Rose, K. L.  et al. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J. C lin. Invest. 118, 608\u2013618 (2008).","journal-title":"J. C lin. Invest."},{"key":"BFnrneph201085_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrd3011","volume":"9","author":"E Wagner","year":"2010","unstructured":"Wagner, E. & Frank, M. M. Therapeutic potential of complement modulation. Nat. Rev. Drug Discov. 9, 43\u201356 (2010).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.85","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:34:48Z","timestamp":1684456488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,6]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFnrneph201085"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.85","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,6]]}}}